A Aralex Aachen research explorer

July 13, 2010 article Open access

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

DOI: 10.1182/blood-2010-05-282780 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 7 stored of 1,305

Regulation of immune checkpoint molecules in cancer immune evasion and therapy
2026 Nature reviews. Cancer review Medicine Cancer Immunotherapy and Biomarkers

4

citations
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 Science article Medicine Cancer Immunotherapy and Biomarkers Open access

191

citations
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features
2024 Blood Advances article Medicine Lymphoma Diagnosis and Treatment Open access

10

citations
Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors
2023 Molecular Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent

88

citations
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapy
2022 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Immune cells in cancer Open access

6

citations
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
2022 Leukemia article Medicine Lymphoma Diagnosis and Treatment Open access cited by 4 patents

4,055

citations
PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
2020 Frontiers in Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access

114

citations

7 results

References 0